Randy D. Pryka
- Pharmacology top 5%
- Infectious Diseases top 10%
- Epidemiology
- Pediatrics, Perinatology and Child Health
- Clinical Biochemistry top 10%
- Co-authors
- Keith A. RodvoldJohn C. RotschaferDonna M. KrausMark W. GarrisonGeorge M. HaigRobert A. BlumDaniel HaverstockSteven F. Kowalsky
- Topics
- Antibiotics Pharmacokinetics and Efficacy (9 papers)Pneumonia and Respiratory Infections (4 papers)Antimicrobial Resistance in Staphylococcus (4 papers)
- Partner nations
- United States
In The Last Decade
Randy D. Pryka
14 papers receiving 332 citations
Peers
Comparison fields: 5 of 57
- Pharmacology 257
- Infectious Diseases 174
- Epidemiology 107
- Pediatrics, Perinatology and Child Health 66
- Clinical Biochemistry 58
Countries citing papers authored by Randy D. Pryka
This map shows the geographic impact of Randy D. Pryka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy D. Pryka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy D. Pryka more than expected).
Fields of papers citing papers by Randy D. Pryka
This network shows the impact of papers produced by Randy D. Pryka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy D. Pryka. The network helps show where Randy D. Pryka may publish in the future.
Co-authorship network of co-authors of Randy D. Pryka
This figure shows the co-authorship network connecting the top 25 collaborators of Randy D. Pryka. A scholar is included among the top collaborators of Randy D. Pryka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randy D. Pryka. Randy D. Pryka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 83 | |
| 3 | 25 | |
| 4 | 6 | |
| 5 | 11 | |
| 6 | 10 | |
| 7 | 41 | |
| 8 | 34 | |
| 9 | 16 | |
| 10 | 9 | |
| 11 | 39 | |
| 12 | 1 | |
| 13 | 44 | |
| 14 | Teicoplanin: an investigational glycopeptide antibiotic. | 18 |
About Randy D. Pryka
Randy D. Pryka is a scholar working on Microbiology, Pharmacology and Applied Microbiology and Biotechnology, having authored 14 papers that have together received 347 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Pneumonia and Respiratory Infections (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). The work is most often cited by research in Pharmacology (257 citations), Infectious Diseases (174 citations) and Clinical Biochemistry (58 citations). Randy D. Pryka has collaborated with scholars based in United States. Frequent co-authors include Keith A. Rodvold, John C. Rotschafer, Donna M. Kraus, Mark W. Garrison, George M. Haig, Robert A. Blum, Daniel Haverstock, Steven F. Kowalsky, David K. Wagner and Rodger Novak. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Clinical Pharmacokinetics and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.